Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Apr 1;19(4):255–264. doi: 10.1089/dia.2016.0405

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Allen B. King et al., 2017; Published by Mary Ann Liebert, Inc.

This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

PMC Copyright notice

FIG. 2. — Time (%) above (IG ≥9.0 mmol/L), within (3.9≤ IG <9.0 mmol/L) and below (IG <3.9 mmol/L) IG target range* for patients in the DUAL I extension CGM sub-study. Sub-study analysis set. *IG target range: 3.9 to <9.0 mmol/L. Analysis is based on observed data using an ANCOVA method for time/duration, and a negative binomial regression model for episodes (using a log link and the logarithm of the profile duration as offset) with treatment, region, baseline HbA_1c stratum (≤8.3% [≤67 mmol/mol], >8.3% [>67 mmol/mol]) and previous OAD treatment as fixed effects for both methods. CGM, continuous glucose monitoring; CI, confidence interval; IG, interstitial glucose; Lira, liraglutide; SD, standard deviation.